Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

AIMS: To determine the effects of empagliflozin on adiposity indices among patients with type 2 diabetes mellitus. METHODS: Changes in weight, waist circumference, estimated total body fat, index of central obesity and visceral adiposity index were assessed using analysis of covariance and testing o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diab Vasc Dis Res
Main Authors: Neeland, Ian J, McGuire, Darren K, Chilton, Robert, Crowe, Susanne, Lund, Søren S, Woerle, Hans J, Broedl, Uli C, Johansen, Odd Erik
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768401/
https://ncbi.nlm.nih.gov/pubmed/26873905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164115616901
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados